documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
59 rows where docket_id = "FDA-2013-N-0002" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
document_type 4
- Rule 26
- Supporting & Related Material 26
- Other 4
- Notice 3
agency_id 1
- FDA 59
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-0002-0057 | FDA | None FDA-2013-N-0002 | Pulmotil AC (aqueous tilmicosin) Environmental Assessment for the Use of Pulmotil AC to Control Swine Respiratory Disease | Other | Background Material | 2014-04-09T04:00:00Z | 2014 | 4 | 2014-04-09T04:00:00Z | 2014-04-09T12:45:38Z | 0 | 0 | 09000064816aa8f6 | ||
| FDA-2013-N-0002-0058 | FDA | None FDA-2013-N-0002 | ENVIRONMENTAL ASSESSMENT for AQUAFLOR (Florfenicol) 50% Type A Medicated Article | Other | Background Material | 2014-04-09T04:00:00Z | 2014 | 4 | 2014-04-09T04:00:00Z | 2014-04-09T12:51:55Z | 0 | 0 | 09000064816aa8f7 | ||
| FDA-2013-N-0002-0056 | FDA | None FDA-2013-N-0002 | Finding of No Significant Impact FONSI For AQUAFLOR Florfenicol 50 percent Type A Medicated Article | Other | Background Material | 2014-04-09T04:00:00Z | 2014 | 4 | 2014-04-09T04:00:00Z | 2014-04-09T12:40:34Z | 0 | 0 | 09000064816aa8f5 | ||
| FDA-2013-N-0002-0059 | FDA | None FDA-2013-N-0002 | Finding of No Significant Impact (FONSI) for PULMOTIL AC Aqueous Concentrate (Tilmicosin) in Swine for the Control of Swine Respiratory Disease | Other | Background Material | 2014-04-09T04:00:00Z | 2014 | 4 | 2014-04-09T04:00:00Z | 2014-04-09T12:55:59Z | 0 | 0 | 09000064816aa8f8 | ||
| FDA-2013-N-0002-0052 | FDA | None FDA-2013-N-0002 | FREEDOM OF INFORMATION SUMMARY NADA 141-361 PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate Swine | Supporting & Related Material | Freedom of Information Summary | 2014-04-08T04:00:00Z | 2014 | 4 | 2014-04-08T16:29:38Z | 0 | 0 | 09000064816a892c | |||
| FDA-2013-N-0002-0053 | FDA | None FDA-2013-N-0002 | FREEDOM OF INFORMATION SUMMARY NADA141-420 TILDREN tiludronate disodium Powder for injection Horse | Supporting & Related Material | Freedom of Information Summary | 2014-04-08T04:00:00Z | 2014 | 4 | 2014-04-08T16:32:40Z | 0 | 0 | 09000064816a892d | |||
| FDA-2013-N-0002-0055 | FDA | None FDA-2013-N-0002 | FREEDOM OF INFORMATION SUMMARY NADA 130-185 AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins | Supporting & Related Material | Freedom of Information Summary | 2014-04-08T04:00:00Z | 2014 | 4 | 2014-04-08T16:36:57Z | 0 | 0 | 09000064816a8b80 | |||
| FDA-2013-N-0002-0054 | FDA | None FDA-2013-N-0002 | FREEDOM OF INFORMATION SUMMARY Application Number 141-422 PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog | Supporting & Related Material | Freedom of Information Summary | 2014-04-08T04:00:00Z | 2014 | 4 | 2014-04-08T16:35:08Z | 0 | 0 | 09000064816a892e | |||
| FDA-2013-N-0002-0051 | FDA | None FDA-2013-N-0002 | FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR Florfenicol | Supporting & Related Material | Freedom of Information Summary | 2014-04-08T04:00:00Z | 2014 | 4 | 2014-04-08T16:22:29Z | 0 | 0 | 09000064816a892b | |||
| FDA-2013-N-0002-0050 | FDA | None FDA-2013-N-0002 | New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin; Florfenicol; Florfenicol and Flunixin; Paclitaxel; Phenylbutazone; Pimobendan; Salinomycin; Tilmicosin; Tiludronate; Change of Sponsor | Rule | Final Rule | 2014-04-01T04:00:00Z | 2014 | 4 | 2014-04-01T04:00:00Z | 2014-04-01T13:05:54Z | 2014-07220 | 0 | 0 | 0900006481694311 | |
| FDA-2013-N-0002-0048 | FDA | None FDA-2013-N-0002 | Current Good Manufacturing Practice for Medicated Feeds | Rule | Final Rule | 2014-01-23T05:00:00Z | 2014 | 1 | 2014-01-23T05:00:00Z | 2014-01-23T17:39:42Z | 2014-01299 | 0 | 0 | 090000648151cdd1 | |
| FDA-2013-N-0002-0047 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Argent Laboratories; Formalin; Tricaine Methanesulfonate | Rule | Final Rule | 2014-01-16T05:00:00Z | 2014 | 1 | 2014-01-16T05:00:00Z | 2014-01-16T15:17:57Z | 2014-00721 | 0 | 0 | 090000648150d6c6 | |
| FDA-2013-N-0002-0046 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Argent Laboratories; Formalin; Tricaine Methanesulfonate | Rule | Withdrawal | 2014-01-16T05:00:00Z | 2014 | 1 | 2014-01-16T05:00:00Z | 2014-01-16T15:01:12Z | 2014-00722 | 0 | 0 | 090000648150d714 | |
| FDA-2013-N-0002-0045 | FDA | None FDA-2013-N-0002 | New Animal Drugs for Use in Animal Feeds; Bambermycins; Correction | Rule | Correction | 2013-12-30T05:00:00Z | 2013 | 12 | 2013-12-30T05:00:00Z | 2013-12-30T15:28:01Z | 2013-31184 | 0 | 0 | 09000064814e1974 | |
| FDA-2013-N-0002-0049 | FDA | None FDA-2013-N-0002 | Approvals of New Animal Drug Applications Withdrawals Roxarsone | Rule | Final Rule | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2014-01-25T23:25:40Z | 2013-30837 | 0 | 0 | 09000064814de405 | |
| FDA-2013-N-0002-0044 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Roxarsone | Rule | Final Rule | 2013-12-27T05:00:00Z | 2013 | 12 | 2013-12-27T05:00:00Z | 2013-12-27T15:39:48Z | 2013-30838 | 0 | 0 | 09000064814de527 | |
| FDA-2013-N-0002-0043 | FDA | None FDA-2013-N-0002 | New Animal Drugs for Use in Animal Feeds; Bambermycins | Rule | Final Rule | 2013-12-16T05:00:00Z | 2013 | 12 | 2013-12-16T05:00:00Z | 2013-12-16T17:30:57Z | 2013-29810 | 0 | 0 | 09000064814c1cc8 | |
| FDA-2013-N-0002-0042 | FDA | None FDA-2013-N-0002 | New Animal Drugs: Hyaluronate Sodium; Hydrogen Peroxide; Imidacloprid and Moxidectin; Change of Sponsor | Rule | Final Rule | 2013-12-09T05:00:00Z | 2013 | 12 | 2013-12-10T11:17:01Z | 2013-29234 | 0 | 0 | 09000064814b25e6 | ||
| FDA-2013-N-0002-0041 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid | Rule | Final Rule | 2013-11-26T05:00:00Z | 2013 | 11 | 2013-11-26T05:00:00Z | 2013-11-26T14:21:13Z | 2013-28256 | 0 | 0 | 09000064814989b3 | |
| FDA-2013-N-0002-0040 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid | Notice | General Notice | 2013-11-26T05:00:00Z | 2013 | 11 | 2013-11-26T05:00:00Z | 2013-11-26T14:17:06Z | 2013-28255 | 0 | 0 | 0900006481498795 | |
| FDA-2013-N-0002-0039 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone | Rule | Final Rule | 2013-11-22T05:00:00Z | 2013 | 11 | 2013-11-22T05:00:00Z | 2013-11-22T14:42:39Z | 2013-27917 | 0 | 0 | 0900006481491103 | |
| FDA-2013-N-0002-0038 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone | Notice | General Notice | 2013-11-22T05:00:00Z | 2013 | 11 | 2013-11-22T05:00:00Z | 2013-11-22T14:37:17Z | 2013-27916 | 0 | 0 | 09000064814910b5 | |
| FDA-2013-N-0002-0036 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin | Supporting & Related Material | Freedom of Information Summary | 2013-11-05T05:00:00Z | 2013 | 11 | 2013-11-05T17:24:32Z | 0 | 0 | 09000064814711c6 | |||
| FDA-2013-N-0002-0034 | FDA | None FDA-2013-N-0002 | New Animal Drugs: Afoxolaner, Carprofen, Ceftiofur Hydrochloride, Monensin | Rule | Final Rule | 2013-11-05T05:00:00Z | 2013 | 11 | 2013-11-05T05:00:00Z | 2013-11-05T16:41:31Z | 2013-26473 | 0 | 0 | 0900006481470b65 | |
| FDA-2013-N-0002-0037 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride | Supporting & Related Material | Freedom of Information Summary | 2013-11-05T05:00:00Z | 2013 | 11 | 2013-11-05T17:34:49Z | 0 | 0 | 0900006481471240 | |||
| FDA-2013-N-0002-0035 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet | Supporting & Related Material | Freedom of Information Summary | 2013-11-05T05:00:00Z | 2013 | 11 | 2013-11-05T17:00:27Z | 0 | 0 | 09000064814706c5 | |||
| FDA-2013-N-0002-0028 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 139-237 Lactating Dairy Cows | Supporting & Related Material | Freedom of Information Summary | 2013-10-25T04:00:00Z | 2013 | 10 | 2013-10-25T13:44:45Z | 0 | 0 | 090000648145e676 | |||
| FDA-2013-N-0002-0030 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 141-360 EQUISUL-SDT Sulfadiazine/Trimethoprim Horses | Supporting & Related Material | Freedom of Information Summary | 2013-10-25T04:00:00Z | 2013 | 10 | 2013-10-25T14:04:49Z | 0 | 0 | 090000648145e7f0 | |||
| FDA-2013-N-0002-0032 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine | Supporting & Related Material | Freedom of Information Summary | 2013-10-25T04:00:00Z | 2013 | 10 | 2013-10-25T14:32:31Z | 0 | 0 | 090000648145e8f7 | |||
| FDA-2013-N-0002-0033 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter | Supporting & Related Material | Freedom of Information Summary | 2013-10-25T04:00:00Z | 2013 | 10 | 2013-10-25T14:31:20Z | 0 | 0 | 090000648145e8fc | |||
| FDA-2013-N-0002-0029 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 141-349 DRAXXIN 25 Injectable Solution, Tulathromycin, Swine | Supporting & Related Material | Freedom of Information Summary | 2013-10-25T04:00:00Z | 2013 | 10 | 2013-10-25T13:58:47Z | 0 | 0 | 090000648145e677 | |||
| FDA-2013-N-0002-0031 | FDA | None FDA-2013-N-0002 | New Animal Drugs; Change of Sponsor: Gonadorelin, Ivermectin, Ractopamine, Trimethoprim and Sulfadiazine Suspension, Tulathromycin | Rule | Final Rule | 2013-10-25T04:00:00Z | 2013 | 10 | 2013-10-25T04:00:00Z | 2013-10-25T14:19:29Z | 2013-25172 | 0 | 0 | 090000648145feec | |
| FDA-2013-N-0002-0027 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-550 MELOXIDYL Meloxicam | Supporting & Related Material | Freedom of Information Summary | 2013-09-20T04:00:00Z | 2013 | 9 | 2013-09-20T14:17:02Z | 0 | 0 | 090000648142d5dd | |||
| FDA-2013-N-0002-0026 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-514 BOVIPROL 9.6% Oral Solution Amprolium Cattle/Calves | Supporting & Related Material | Freedom of Information Summary | 2013-09-20T04:00:00Z | 2013 | 9 | 2013-09-20T14:03:03Z | 0 | 0 | 090000648142d5dc | |||
| FDA-2013-N-0002-0025 | FDA | None FDA-2013-N-0002 | Oral Dosage Form New Animal Drugs: Amprolium; Meloxicam | Rule | Final Rule | 2013-09-17T04:00:00Z | 2013 | 9 | 2013-09-17T04:00:00Z | 2013-09-17T15:23:49Z | 2013-22523 | 0 | 0 | 09000064814276a4 | |
| FDA-2013-N-0002-0024 | FDA | None FDA-2013-N-0002 | New Animal Drugs: Carprofen; Enrofloxacin; Florfenicol; Tildipirosin; Zilpaterol | Rule | Final Rule | 2013-08-27T04:00:00Z | 2013 | 8 | 2013-08-27T04:00:00Z | 2013-12-10T11:40:18Z | 2013-20538 | 0 | 0 | 09000064813c6a82 | |
| FDA-2013-N-0002-0022 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Quali-Tech Products, Inc.; Bambermycins; Pyrantel; Tylosin; Virginiamycin | Notice | Withdrawal | 2013-08-23T04:00:00Z | 2013 | 8 | 2013-08-23T04:00:00Z | 2013-08-23T15:35:16Z | 2013-20615 | 0 | 0 | 09000064813c11f6 | |
| FDA-2013-N-0002-0023 | FDA | None FDA-2013-N-0002 | Withdrawal of Approval of New Animal Drug Applications; Quali-Tech Products, Inc.; Bambermycins; Pyrantel; Tylosin; Virginiamycin | Rule | Final Rule | 2013-08-23T04:00:00Z | 2013 | 8 | 2013-08-23T04:00:00Z | 2013-08-23T15:22:26Z | 2013-20616 | 0 | 0 | 09000064813c1175 | |
| FDA-2013-N-0002-0021 | FDA | None FDA-2013-N-0002 | New Animal Drugs; Change of Sponsor; Fentanyl; Iron Injection | Rule | Final Rule | 2013-07-24T04:00:00Z | 2013 | 7 | 2013-07-24T04:00:00Z | 2013-07-24T14:40:15Z | 2013-17754 | 0 | 0 | 0900006481379e58 | |
| FDA-2013-N-0002-0019 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary NADA 141-345 APOQUEL (oclacitinib tablet) | Supporting & Related Material | Freedom of Information Summary | 2013-07-15T04:00:00Z | 2013 | 7 | 2013-07-15T15:48:56Z | 0 | 0 | 0900006481366402 | |||
| FDA-2013-N-0002-0018 | FDA | None FDA-2013-N-0002 | Oral Dosage Form New Animal Drugs; Nicarbazin; Oclacitinib; Zilpaterol | Rule | Final Rule | 2013-07-15T04:00:00Z | 2013 | 7 | 2013-07-15T04:00:00Z | 2013-07-15T15:40:23Z | 2013-16258 | 0 | 0 | 09000064813666f8 | |
| FDA-2013-N-0002-0020 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-544 ZILMAX plus RUMENSIN plus TYLOVET 100 plus MGA | Supporting & Related Material | Reference (internal unless indicated) | 2013-07-15T04:00:00Z | 2013 | 7 | 2013-07-15T15:56:17Z | 0 | 0 | 0900006481366403 | |||
| FDA-2013-N-0002-0017 | FDA | None FDA-2013-N-0002 | New Animal Drugs; Dexmedetomidine; Lasalocid; Melengestrol; Monensin; and Tylosin; Correction | Rule | Correction | 2013-06-05T04:00:00Z | 2013 | 6 | 2013-06-05T04:00:00Z | 2013-06-05T14:01:32Z | 2013-13331 | 0 | 0 | 090000648130b953 | |
| FDA-2013-N-0002-0016 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-551 Enrofloxacin Flavored Tablets | Supporting & Related Material | Freedom of Information Summary | 2013-05-22T04:00:00Z | 2013 | 5 | 2013-05-22T14:18:38Z | 0 | 0 | 09000064812f25ab | |||
| FDA-2013-N-0002-0014 | FDA | None FDA-2013-N-0002 | Oral Dosage Form New Animal Drugs; Clindamycin; Enrofloxacin | Rule | Final Rule | 2013-05-22T04:00:00Z | 2013 | 5 | 2013-05-22T04:00:00Z | 2013-05-22T13:54:39Z | 2013-12134 | 0 | 0 | 09000064812f2154 | |
| FDA-2013-N-0002-0015 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-538 CLINDAMED Oral Drops | Supporting & Related Material | Freedom of Information Summary | 2013-05-22T04:00:00Z | 2013 | 5 | 2013-05-22T14:09:47Z | 0 | 0 | 09000064812f2586 | |||
| FDA-2013-N-0002-0013 | FDA | None FDA-2013-N-0002 | New Animal Drugs; Change of Sponsor's Name and Address; Change of Sponsor | Rule | Final Rule | 2013-05-13T04:00:00Z | 2013 | 5 | 2013-05-13T04:00:00Z | 2013-05-13T13:30:45Z | 2013-11283 | 0 | 0 | 09000064812dfc63 | |
| FDA-2013-N-0002-0012 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-535 Melengestrol acetate plus lasalocid sodium plus tylosin phosphate | Supporting & Related Material | Freedom of Information Summary | 2013-04-30T04:00:00Z | 2013 | 4 | 2013-04-30T14:12:34Z | 0 | 0 | 09000064812ad2f7 | |||
| FDA-2013-N-0002-0010 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-532 MGA plus TYLOVET 100 | Supporting & Related Material | Freedom of Information Summary | 2013-04-30T04:00:00Z | 2013 | 4 | 2013-04-30T13:49:36Z | 0 | 0 | 09000064812ad28f | |||
| FDA-2013-N-0002-0009 | FDA | None FDA-2013-N-0002 | New Animal Drugs; Dexmedetomidine; Lasalocid; Melengestrol; Monensin; and Tylosin | Rule | Final Rule | 2013-04-30T04:00:00Z | 2013 | 4 | 2013-04-30T04:00:00Z | 2013-04-30T13:30:05Z | 2013-10152 | 0 | 0 | 09000064812ad9a8 | |
| FDA-2013-N-0002-0011 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-533 DECCOX plus RUMENSIN plus TYLOVET 100 (decoquinate plus monensin USP plus tylosin phosphate) | Supporting & Related Material | Reference (internal unless indicated) | 2013-04-30T04:00:00Z | 2013 | 4 | 2013-04-30T14:03:23Z | 0 | 0 | 09000064812ad2f5 | |||
| FDA-2013-N-0002-0008 | FDA | None FDA-2013-N-0002 | New Animal Drugs: Change of Sponsor | Rule | Final Rule | 2013-04-09T04:00:00Z | 2013 | 4 | 2013-04-09T04:00:00Z | 2013-04-09T14:02:58Z | 2013-07542 | 0 | 0 | 0900006481289e2d | |
| FDA-2013-N-0002-0005 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary re Abbreviated New Animal Drug Application ANADA 200-495 ENROFLOX 100 Enrofloxacin Injectable Solution Beef and Non-Lactating Dairy Cattle Swine | Supporting & Related Material | Freedom of Information Summary | 2013-04-03T04:00:00Z | 2013 | 4 | 2013-12-10T12:05:33Z | 0 | 0 | 09000064812642ee | |||
| FDA-2013-N-0002-0007 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary re Abbreviated New Animal Drug Application ANADA 20TYLOVET 100 Tylosin Phosphate and RUMENSIN Monensin 200-531 Type Articles For Use in the Manufacture of Type B and Medicated Feeds | Supporting & Related Material | Freedom of Information Summary | 2013-04-03T04:00:00Z | 2013 | 4 | 2013-12-10T12:09:28Z | 0 | 0 | 0900006481264a82 | |||
| FDA-2013-N-0002-0004 | FDA | None FDA-2013-N-0002 | New Animal Drugs: Enrofloxacin; Tilmicosin; Tylosin | Rule | Final Rule | 2013-04-03T04:00:00Z | 2013 | 4 | 2013-04-03T04:00:00Z | 2013-04-03T15:12:51Z | 2013-07571 | 0 | 0 | 0900006481263219 | |
| FDA-2013-N-0002-0006 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary re Abbreviated New Animal Drug Application ANADA 200-509 TILMOVET 90 Tilmicosin Phosphate Type A Medicated Article | Supporting & Related Material | Freedom of Information Summary | 2013-04-03T04:00:00Z | 2013 | 4 | 2013-12-10T12:11:23Z | 0 | 0 | 0900006481264910 | |||
| FDA-2013-N-0002-0003 | FDA | None FDA-2013-N-0002 | Freedom of Information Summary ANADA 200-541 GONABREED Gonadorelin Acetate Injectable Solution Dairy Cattle | Supporting & Related Material | Freedom of Information Summary | 2013-03-26T04:00:00Z | 2013 | 3 | 2013-12-10T11:54:59Z | 0 | 0 | 0900006481243b6a | |||
| FDA-2013-N-0002-0002 | FDA | None FDA-2013-N-0002 | New Animal Drug Approvals: Change of Sponsor; Change of Sponsor's Drug Labeler Code; Gonadorelin Acetate; Isoflurane; Praziquantel; Propofol; Sevoflurane; Triamcinolone Acetonide | Rule | Final Rule | 2013-03-25T04:00:00Z | 2013 | 3 | 2013-03-25T04:00:00Z | 2013-12-10T11:54:02Z | 2013-06748 | 0 | 0 | 090000648124175f | |
| FDA-2013-N-0002-0001 | FDA | None FDA-2013-N-0002 | New Animal Drugs: Sponsor Changes | Rule | Final Rule | 2013-03-22T04:00:00Z | 2013 | 3 | 2013-03-22T04:00:00Z | 2013-03-22T13:17:57Z | 2013-06126 | 0 | 0 | 090000648123d536 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;